Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
12 2021
Historique:
received: 15 05 2021
revised: 11 09 2021
accepted: 27 09 2021
pubmed: 6 10 2021
medline: 21 12 2021
entrez: 5 10 2021
Statut: ppublish

Résumé

Growing evidence documented the critical impacts of vitamin D (VD) in the prognosis of COVID-19 patients. The functions of VD are dependent on the vitamin D receptor (VDR) in the VD/VDR signaling pathway. Therefore, we aimed to assess the association of VDR gene polymorphisms with COVID-19 outcomes. In the present study, eight VDR single nucleotide polymorphisms (SNPs) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 500 COVID-19 patients in Iran, including 160 asymptomatic, 250 mild/moderate, and 90 severe/critical cases. The association of these polymorphisms with severity, clinical outcomes, and comorbidities were evaluated through the calculation of the Odds ratio (OR). Interestingly, significant associations were disclosed for some of the SNP-related alleles and/or genotypes in one or more genetic models with different clinical data in COVID-19 patients. Significant association of VDR-SNPs with signs, symptoms, and comorbidities was as follows: ApaI with shortness of breath (P ˂ 0.001) and asthma (P = 0.034) in severe/critical patients (group III); BsmI with chronic renal disease (P = 0.010) in mild/moderate patients (group II); Tru9I with vomiting (P = 0.031), shortness of breath (P = 0.04), and hypertension (P = 0.030); FokI with fever and hypertension (P = 0.027) in severe/critical patients (group III); CDX2 with shortness of breath (P = 0.022), hypertension (P = 0.036), and diabetes (P = 0.042) in severe/critical patients (group III); EcoRV with diabetes (P ˂ 0.001 and P = 0.045 in mild/moderate patients (group II) and severe/critical patients (group III), respectively). However, the association of VDR TaqI and BglI polymorphisms with clinical symptoms and comorbidities in COVID-19 patients was not significant. VDR gene polymorphisms might play critical roles in the vulnerability to infection and severity of COVID-19, probably by altering the risk of comorbidities. However, these results require further validation in larger studies with different ethnicities and geographical regions.

Identifiants

pubmed: 34610433
pii: S1567-1348(21)00398-1
doi: 10.1016/j.meegid.2021.105098
pmc: PMC8487094
pii:
doi:

Substances chimiques

Receptors, Calcitriol 0
VDR protein, human 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105098

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Br J Cancer. 2004 Aug 16;91(4):765-70
pubmed: 15238985
Rev Cardiovasc Med. 2020 Sep 30;21(3):339-344
pubmed: 33070539
Eur J Immunol. 2007 Feb;37(2):395-405
pubmed: 17274004
Ann Intensive Care. 2020 Jul 31;10(1):99
pubmed: 32737627
Genes (Basel). 2020 Aug 27;11(9):
pubmed: 32867305
Isr Med Assoc J. 2017 Jul;19(7):438-443
pubmed: 28786260
Clin Med (Lond). 2020 Jul;20(4):e107-e108
pubmed: 32503801
Mol Med Rep. 2016 Feb;13(2):1186-94
pubmed: 26675943
J Infect Public Health. 2020 Oct;13(10):1373-1380
pubmed: 32605780
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
J Clin Oncol. 2020 Nov 20;38(33):3914-3924
pubmed: 32986528
Int J Neurosci. 2018 Jun;128(6):505-511
pubmed: 29072967
Hum Mol Genet. 1993 Apr;2(4):487
pubmed: 8099305
Korean J Intern Med. 2018 Nov;33(6):1129-1136
pubmed: 29914229
J Endocrinol Invest. 2021 Apr;44(4):765-771
pubmed: 32772324
Eur J Clin Nutr. 2020 Nov;74(11):1498-1513
pubmed: 31959942
J Steroid Biochem Mol Biol. 2020 Sep;202:105719
pubmed: 32535032
Gene. 2015 May 1;561(2):171-80
pubmed: 25682935
J Neurol Sci. 2016 Aug 15;367:148-51
pubmed: 27423580
Hum Genet. 2010 Feb;127(2):207-21
pubmed: 19902255
Mult Scler. 2009 May;15(5):563-70
pubmed: 19383647
Thorax. 2015 Jul;70(7):617-24
pubmed: 25903964
Rev Endocr Metab Disord. 2001 Apr;2(2):203-16
pubmed: 11705326
Mol Cell Endocrinol. 2001 May 25;177(1-2):145-59
pubmed: 11377830
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Pediatr Int. 2015 Oct;57(5):870-4
pubmed: 25808747
Iran J Med Sci. 2018 Mar;43(2):125-139
pubmed: 29749981
Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385-90
pubmed: 9610787
Mol Endocrinol. 1997 Jul;11(8):1165-79
pubmed: 9212063
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Int Urol Nephrol. 2020 Jun;52(6):1193-1194
pubmed: 32222883
Virus Res. 2008 Apr;133(1):13-9
pubmed: 17374415
BMJ Open Respir Res. 2015 Jun 13;2(1):e000074
pubmed: 26113982
Gene. 2018 Dec 15;678:384-394
pubmed: 30092343
Clin Endocrinol (Oxf). 2000 Feb;52(2):211-6
pubmed: 10671949
Inflamm Allergy Drug Targets. 2013 Aug;12(4):253-61
pubmed: 23782208
Am J Clin Nutr. 2016 Jul;104(1):205-14
pubmed: 27194308
Brain Sci. 2020 May 08;10(5):
pubmed: 32397275
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
J Steroid Biochem Mol Biol. 2013 Jan;133:51-7
pubmed: 22960018
Dermatoendocrinol. 2013 Jan 1;5(1):51-108
pubmed: 24494042
Sci Rep. 2020 Dec 11;10(1):21805
pubmed: 33311519
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Immunogenetics. 2018 Aug;70(8):523-532
pubmed: 29808256
Int J Infect Dis. 2020 May;94:119-124
pubmed: 32247050
Rev Med Virol. 2017 Jan;27(1):
pubmed: 27714929
Biochem Genet. 2019 Jun;57(3):355-370
pubmed: 30456721
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
Nature. 1994 Jan 20;367(6460):284-7
pubmed: 8161378
Biochem Pharmacol. 2020 Jul;177:113955
pubmed: 32251673
Ir Med J. 2020 May 07;113(5):84
pubmed: 32603575
Dermatology. 2012;224(4):361-8
pubmed: 22738935
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
Hum Genomics. 2020 Oct 22;14(1):40
pubmed: 33092637
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13
pubmed: 34144110
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320926899
pubmed: 32408793
Clin Chim Acta. 2006 Sep;371(1-2):1-12
pubmed: 16563362
Gene. 2020 Dec 15;762:145102
pubmed: 32882331
Pediatr Pulmonol. 2014 Aug;49(8):790-9
pubmed: 24019226
Am Heart J. 2014 Mar;167(3):283-91
pubmed: 24576510
Naunyn Schmiedebergs Arch Pharmacol. 2020 Jul;393(7):1157-1160
pubmed: 32451597
HLA. 2020 Aug;96(2):194-196
pubmed: 32424945
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
J Diabetes Metab Disord. 2021 Aug 23;20(2):1375-1383
pubmed: 34900789
PLoS One. 2014 Apr 30;9(4):e96105
pubmed: 24787735
Mol Med Rep. 2017 Nov;16(5):7432-7438
pubmed: 28944831
J Glob Antimicrob Resist. 2020 Sep;22:133-134
pubmed: 32474141
Cancer Lett. 2008 Feb 18;260(1-2):209-15
pubmed: 18079052
BMC Genet. 2005 Jan 15;6:2
pubmed: 15651992
Clin Ther. 2017 May;39(5):946-957
pubmed: 28476406
J Dermatol Sci. 2014 Jan;73(1):63-6
pubmed: 24055231
J Natl Cancer Inst. 2021 Apr 6;113(4):371-380
pubmed: 33136163
Nutrients. 2020 Apr 02;12(4):
pubmed: 32252338
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Anticancer Res. 2009 Sep;29(9):3511-36
pubmed: 19667145
BMC Med. 2020 Jul 15;18(1):216
pubmed: 32664879
J Intern Med. 2021 Jan;289(1):97-115
pubmed: 32613681
BMC Med Genet. 2019 Dec 10;20(1):193
pubmed: 31822280
Oncologist. 2021 Aug;26(8):685-693
pubmed: 33856099
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):303-310
pubmed: 32298981
Steroids. 2020 Jun;158:108615
pubmed: 32097613
Aging Clin Exp Res. 2020 Jul;32(7):1195-1198
pubmed: 32377965
J Bone Miner Res. 2003 Sep;18(9):1632-41
pubmed: 12968672
Mol Endocrinol. 2013 Dec;27(12):2116-25
pubmed: 24196349
Aliment Pharmacol Ther. 2019 Jan;49(2):173-182
pubmed: 30484857
Mol Endocrinol. 2000 Mar;14(3):401-20
pubmed: 10707958

Auteurs

Rasoul Abdollahzadeh (R)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: RASOUL142857@gmail.com.

Mohammad Hossein Shushizadeh (MH)

Pasteur Medical Lab, Shush Danial, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Mina Barazandehrokh (M)

Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran.

Sepideh Choopani (S)

Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Asaad Azarnezhad (A)

Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. Electronic address: asad.azarnezhad@muk.ac.ir.

Sahereh Paknahad (S)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Maryam Pirhoushiaran (M)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

S Zahra Makani (SZ)

Babol Razi Pathology and Genetic Laboratory, Babol, Iran.

Razieh Zarifian Yeganeh (RZ)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Ahmed Al-Kateb (A)

Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Ahmedalaakateb@gmail.com.

Roozbeh Heidarzadehpilehrood (R)

Department of Obstetrics & Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia. Electronic address: roozbeh.heidarzadeh@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH